Cancer Res:成纤维细胞HIF-1α的作用被揭示

2012-06-26 Beyond 生物谷

实体肿瘤组织包括恶性肿瘤细胞和相关基质成分,包括成纤维细胞、肿瘤相关巨噬细胞等,这些非肿瘤细胞的存在有助于促进肿瘤的生长和进展。 在晚期肿瘤组织中,我们经常发现肿瘤间质纤维化和血管异常的存在,而这两种现象都与肿瘤组织的缺氧有关,但一直以来肿瘤相关成纤维细胞内的缺氧信号对肿瘤发生发展的贡献仍然不甚明了。 最近刊登在Cancer Research杂志上的一则新研究中,研究人员用成纤维细胞特异性启动

实体肿瘤组织包括恶性肿瘤细胞和相关基质成分,包括成纤维细胞、肿瘤相关巨噬细胞等,这些非肿瘤细胞的存在有助于促进肿瘤的生长和进展。

在晚期肿瘤组织中,我们经常发现肿瘤间质纤维化和血管异常的存在,而这两种现象都与肿瘤组织的缺氧有关,但一直以来肿瘤相关成纤维细胞内的缺氧信号对肿瘤发生发展的贡献仍然不甚明了。

最近刊登在Cancer Research杂志上的一则新研究中,研究人员用成纤维细胞特异性启动子来构建了一种新型小鼠,该启动子区域调控缺氧的关键基因,包括VHL、HIF-1α、HIF-2α、VEGF-A等,但这种小鼠体内的肿瘤间质成纤维细胞被剔除。这一样以来有助单独考察成纤维细胞所产生的缺氧调控因子的作用,而排出了该细胞产生的其他细胞因子。

研究人员发现,在乳腺癌小鼠模型中HIF-1α及其靶基因VEGF-A的缺失加速肿瘤的生长。 HIF-1α和血管内皮生长因子的缺失还导致血管密度减少和骨髓细胞的浸润,这两者与肿瘤灌注的提高相关。总之,这项研究结果表明成纤维细胞所释放的HIF-1α是肿瘤血管生成的重要调控信号途径。

doi:10.1158/0008-5472.CAN-12-0534
PMC:
PMID:

Loss of Fibroblast HIF-1α Accelerates Tumorigenesis

Jung-whan Kim, Colin Evans, Alexander Weidemann, Norihiko Takeda, Yun Sok Lee, Christian Stockmann, Cristina Branco-Price, Filip Brandberg, Gustavo Leone, Michael C. Ostrowski, and Randall S. Johnson

Solid tumors consist of malignant cells and associated stromal components, including fibroblastic cells that contribute to tumor growth and progression. Although tumor fibrosis and aberrant vascularization contribute to the hypoxia often found in advanced tumors, the contribution of hypoxic signaling within tumor-associated fibroblasts to tumorigenesis remains unknown. In this study, we used a fibroblast-specific promoter to create mice in which key hypoxia regulatory genes, including VHL, HIF-1α, HIF-2α, and VEGF-A, were knocked out specifically in tumor stromal fibroblasts. We found that loss of HIF-1α and its target gene VEGF-A accelerated tumor growth in murine model of mammary cancer. HIF-1α and VEGF-A loss also led to a reduction in vascular density and myeloid cell infiltration, which correlated with improved tumor perfusion. Together, our findings indicate that the fibroblast HIF-1α response is a critical component of tumor vascularization

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1307034, encodeId=f1a7130e034f9, content=<a href='/topic/show?id=6dab540565f' target=_blank style='color:#2F92EE;'>#成纤维细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54056, encryptionId=6dab540565f, topicName=成纤维细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d70341, createdName=zhishijing, createdTime=Thu Jun 28 07:41:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462715, encodeId=b5561462e1578, content=<a href='/topic/show?id=fbbce726228' target=_blank style='color:#2F92EE;'>#纤维细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77262, encryptionId=fbbce726228, topicName=纤维细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c516518840, createdName=marongnuan, createdTime=Thu Jun 28 07:41:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522140, encodeId=ff3e1522140b2, content=<a href='/topic/show?id=1b34881e59' target=_blank style='color:#2F92EE;'>#HIF-1α#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8817, encryptionId=1b34881e59, topicName=HIF-1α)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=847f11414102, createdName=changfy, createdTime=Thu Jun 28 07:41:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556014, encodeId=f991155601443, content=<a href='/topic/show?id=b3e98813c3' target=_blank style='color:#2F92EE;'>#HIF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8813, encryptionId=b3e98813c3, topicName=HIF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=293014689254, createdName=wrj0126, createdTime=Thu Jun 28 07:41:00 CST 2012, time=2012-06-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1307034, encodeId=f1a7130e034f9, content=<a href='/topic/show?id=6dab540565f' target=_blank style='color:#2F92EE;'>#成纤维细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54056, encryptionId=6dab540565f, topicName=成纤维细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d70341, createdName=zhishijing, createdTime=Thu Jun 28 07:41:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462715, encodeId=b5561462e1578, content=<a href='/topic/show?id=fbbce726228' target=_blank style='color:#2F92EE;'>#纤维细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77262, encryptionId=fbbce726228, topicName=纤维细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c516518840, createdName=marongnuan, createdTime=Thu Jun 28 07:41:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522140, encodeId=ff3e1522140b2, content=<a href='/topic/show?id=1b34881e59' target=_blank style='color:#2F92EE;'>#HIF-1α#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8817, encryptionId=1b34881e59, topicName=HIF-1α)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=847f11414102, createdName=changfy, createdTime=Thu Jun 28 07:41:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556014, encodeId=f991155601443, content=<a href='/topic/show?id=b3e98813c3' target=_blank style='color:#2F92EE;'>#HIF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8813, encryptionId=b3e98813c3, topicName=HIF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=293014689254, createdName=wrj0126, createdTime=Thu Jun 28 07:41:00 CST 2012, time=2012-06-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1307034, encodeId=f1a7130e034f9, content=<a href='/topic/show?id=6dab540565f' target=_blank style='color:#2F92EE;'>#成纤维细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54056, encryptionId=6dab540565f, topicName=成纤维细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d70341, createdName=zhishijing, createdTime=Thu Jun 28 07:41:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462715, encodeId=b5561462e1578, content=<a href='/topic/show?id=fbbce726228' target=_blank style='color:#2F92EE;'>#纤维细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77262, encryptionId=fbbce726228, topicName=纤维细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c516518840, createdName=marongnuan, createdTime=Thu Jun 28 07:41:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522140, encodeId=ff3e1522140b2, content=<a href='/topic/show?id=1b34881e59' target=_blank style='color:#2F92EE;'>#HIF-1α#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8817, encryptionId=1b34881e59, topicName=HIF-1α)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=847f11414102, createdName=changfy, createdTime=Thu Jun 28 07:41:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556014, encodeId=f991155601443, content=<a href='/topic/show?id=b3e98813c3' target=_blank style='color:#2F92EE;'>#HIF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8813, encryptionId=b3e98813c3, topicName=HIF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=293014689254, createdName=wrj0126, createdTime=Thu Jun 28 07:41:00 CST 2012, time=2012-06-28, status=1, ipAttribution=)]
    2012-06-28 changfy
  4. [GetPortalCommentsPageByObjectIdResponse(id=1307034, encodeId=f1a7130e034f9, content=<a href='/topic/show?id=6dab540565f' target=_blank style='color:#2F92EE;'>#成纤维细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54056, encryptionId=6dab540565f, topicName=成纤维细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d70341, createdName=zhishijing, createdTime=Thu Jun 28 07:41:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462715, encodeId=b5561462e1578, content=<a href='/topic/show?id=fbbce726228' target=_blank style='color:#2F92EE;'>#纤维细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77262, encryptionId=fbbce726228, topicName=纤维细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c516518840, createdName=marongnuan, createdTime=Thu Jun 28 07:41:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522140, encodeId=ff3e1522140b2, content=<a href='/topic/show?id=1b34881e59' target=_blank style='color:#2F92EE;'>#HIF-1α#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8817, encryptionId=1b34881e59, topicName=HIF-1α)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=847f11414102, createdName=changfy, createdTime=Thu Jun 28 07:41:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556014, encodeId=f991155601443, content=<a href='/topic/show?id=b3e98813c3' target=_blank style='color:#2F92EE;'>#HIF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8813, encryptionId=b3e98813c3, topicName=HIF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=293014689254, createdName=wrj0126, createdTime=Thu Jun 28 07:41:00 CST 2012, time=2012-06-28, status=1, ipAttribution=)]
    2012-06-28 wrj0126

相关资讯

Cancer Res:抑制SOX18降低小鼠黑色素瘤转移

恶性肿瘤细胞从原发部位,经淋巴道, 恶性肿瘤细胞从原发部位,经淋巴道, 血管或体腔等途径,到达其他部位继续生长,称肿瘤转移。 抑制血管生成一直是抗肿瘤转移的一大有效途径。淋巴血管是肿瘤转移的途径之一,在动物模型中抑制肿瘤诱导的新生淋巴管可以有效抑制肿瘤转移。 近日,发育生物学家研究确定了转录因子SOX18在小鼠胚胎淋巴管生成中的关键开关作用。该研究表明SOX18也是肿瘤诱导淋巴管生成的关键,抑

Cancer Dis:JAK3基因突变为淋巴瘤潜在治疗靶标

近日Cancer Discovery杂志上刊登的一项研究显示:NK / T细胞淋巴瘤基本都存在JAK3基因突变。JAK3抑制剂可能有助于治疗这些淋巴瘤患者。 新加坡国立癌症中心医学博士Bin Tean Teh说:在我们开始这项工作之前,很少有人知道是什么样的遗传和分子缺陷导致NK / T细胞淋巴瘤,因此也没有有效的治疗手段,这种类型的癌症预后也极差。 为了确定基因突变,研究人员测序了四名NK/

Cancer Res:CXCL10促进肿瘤溶骨性骨转移

早期研究发现趋化因子CXCL10和RANKL具有促进破骨细胞分化和溶骨性骨转移作用,但在这些过程中,内源性CXCL10的功能却未得到研究。 近日,发表在Cancer Research杂志上的一则新研究中,研究人员揭示了内源性CXCL10对招募癌细胞至骨非常重要,能促进破骨细胞分化,是形成溶骨性骨转移的关键因子。 用中和抗体抑制CXCL10能降低迁移癌症细胞表达CXCL10的受体——CXCR3,

Mol Cancer:异黄酮代谢产物抑制血管生成

一直以来某些植物化学物质包括多酚类物质如黄酮类化合物被认为具有抗癌功效。近日,一新研究证实这些化合物通过抑制肿瘤血管生成发挥其保护作用。新研究中发现一种植物化学物质具有潜在的抗血管生成活性,这不仅对了解这些化合物预防肿瘤的作用机制,同时也为开发新的肿瘤治疗试剂铺平了道路。 在试图找出能降低癌症发病率和死亡率的植物化学物质的道路上,研究人员筛选出了一套迄今未经研究过的植物雌激素的代谢产物。在这项新

Cancer Res:微环境雌激素受体α有助促进血管正常化

雌激素直接促进表达雌激素受体α(ERα)乳腺癌的生长。然而,在肿瘤微环境中基质表达ERα对雌激素的促肿瘤作用具有什么样的贡献从未被探索。 近来,发表在Cancer Research杂志上一则新项研究中,研究人员探讨了了17β-雌二醇(E2)影响肿瘤微环境和调节ERα阴性肿瘤发展的细胞和分子机制。科学家选用不同的ER阴性肿瘤细胞移植到同系免疫去势小鼠皮下,结果发现素E2促进肿瘤的生长,增加肿瘤内血

Cancer Res.:抑制Stat3可强化对B细胞恶性肿瘤的免疫

6月22日,Cancer Research 杂志报道了通过抑制Stat3功能可强化对B细胞恶性肿瘤免疫达到治疗目的。 套细胞淋巴瘤(MCL)是侵袭性且无法治愈的B细胞非霍奇金淋巴瘤的一种亚型。虽然病人往往最初对一线化疗药物和单克隆抗体治疗反应良好,但进一步治疗的反应性却较差,并最终导致复发。 利用免疫系统,诱导针对MCL的免疫特异性并为机体提供长期持久的免疫保护,也许可根除残余的导致疾病复发的